We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$4.21M
Cap. Flow
-$36.2M
Cap. Flow %
-3.4%
Top 10 Hldgs %
45.51%
Holding
2,874
New
227
Increased
1,384
Reduced
630
Closed
115

Top Sells

Rank Stock Value
1
OCSL icon
Oaktree Specialty Lending
OCSL
+$12.7M
2
NVDA icon
NVIDIA
NVDA
+$6.29M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.66M
4
AAPL icon
Apple
AAPL
+$3.19M
5
AVGO icon
Broadcom
AVGO
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 12.25%
3 Healthcare 6.29%
4 Communication Services 4.39%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNL icon
1301
Travel + Leisure Co
TNL
$4.53B
$18.1K ﹤0.01%
402
+114
+40% +$5.11K
HOG icon
1302
Harley-Davidson
HOG
$2.69B
$18K ﹤0.01%
537
-8
-1% -$291
NVEI
1303
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$18K ﹤0.01%
556
+154
+38% +$4.96K
SNN icon
1304
Smith & Nephew
SNN
$12.6B
$18K ﹤0.01%
726
+132
+22% +$3.29K
DK icon
1305
Delek US
DK
$3.71B
$18K ﹤0.01%
725
+281
+63% +$7.77K
JAZZ icon
1306
Jazz Pharmaceuticals
JAZZ
$16.7B
$17.9K ﹤0.01%
168
+33
+24% +$3.63K
VRNS icon
1307
Varonis Systems
VRNS
$5.01B
$17.9K ﹤0.01%
373
+17
+5% +$753
OUT icon
1308
Outfront Media
OUT
$5.43B
$17.9K ﹤0.01%
1,271
+276
+28% +$4.04K
BCH icon
1309
Banco de Chile
BCH
$21B
$17.8K ﹤0.01%
788
+39
+5% +$899
CUBE icon
1310
CubeSmart
CUBE
$9.2B
$17.8K ﹤0.01%
394
+47
+14% +$2.03K
CLS icon
1311
Celestica
CLS
$36.8B
$17.8K ﹤0.01%
310
+111
+56% +$5.6K
PRTA icon
1312
Prothena Corp
PRTA
$439M
$17.8K ﹤0.01%
861
+720
+511% +$15.6K
XPEV icon
1313
XPeng
XPEV
$11.5B
$17.7K ﹤0.01%
2,420
-696
-22% -$5.49K
CYTK icon
1314
Cytokinetics
CYTK
$10.4B
$17.7K ﹤0.01%
327
+129
+65% +$7.79K
R icon
1315
Ryder
R
$10B
$17.7K ﹤0.01%
143
+11
+8% +$1.33K
SKX
1316
DELISTED
Skechers
SKX
$17.6K ﹤0.01%
255
+119
+88% +$7.88K
POWI icon
1317
Power Integrations
POWI
$3.46B
$17.6K ﹤0.01%
251
+174
+226% +$12.5K
PRSU
1318
Pursuit Attractions and Hospitality Inc
PRSU
$1.24B
$17.6K ﹤0.01%
518
+56
+12% +$1.96K
AN icon
1319
AutoNation
AN
$6.88B
$17.5K ﹤0.01%
110
+13
+13% +$2.12K
PPC icon
1320
Pilgrim's Pride
PPC
$6.35B
$17.5K ﹤0.01%
455
AGL icon
1321
Agilon Health
AGL
$1.62B
$17.5K ﹤0.01%
107
+45
+73% +$6.41K
AFG icon
1322
American Financial Group
AFG
$12B
$17.5K ﹤0.01%
142
TKR icon
1323
Timken Company
TKR
$8.79B
$17.5K ﹤0.01%
218
-22
-9% -$1.9K
BCRX icon
1324
BioCryst Pharmaceuticals
BCRX
$2.46B
$17.4K ﹤0.01%
2,818
+2,278
+422% +$12.6K
ACM icon
1325
Aecom
ACM
$9.82B
$17.4K ﹤0.01%
197

Similar funds

Lindbrook Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Lindbrook Capital held 2,874 positions worth $1.06B, down 0.39% from $1.07B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital withdrew a net $36.2M in Q2 2024, closing 115 positions and reducing 630 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lindbrook Capital opened a new position in Nuveen ESG Small-Cap ETF worth $323K.

  • Lindbrook Capital's largest Q2 2024 buy was Nuveen ESG Small-Cap ETF: 8,216 shares worth $323K.
  • Lindbrook Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $3.36M increase.
  • Lindbrook Capital's biggest Q2 2024 reduction was Oaktree Specialty Lending, cutting an estimated $12.7M.
  • Lindbrook Capital fully exited ProShares UltraPro QQQ in Q2 2024, selling an estimated $1.24M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $1.06B portfolio in Q2 2024.
  • Lindbrook Capital opened 227 new positions and closed 115 in Q2 2024.
  • Lindbrook Capital's portfolio value fell 0.39% quarter-over-quarter to $1.06B.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.